The Federal Government has responded to the Review of Medicines and Medical Devices Regulation, whereby reforms will be progressively rolled out over the next 2 years. Baker McKenzie senior associate Amy Middlebrook discusses the changes to advertising rules, the approval of medicines and medical devices, and the process for accessing unapproved medicines.

Explore More Insight